E-therapeutics said it had agreed to work with a global 'top five' pharmaceutical company on a project in a specific area of biology associated with...
Jimmy Groombridge, Executive Director, bought 132 shares in the company on the 12th August 2019 at a price of 113.00p. The Director now holds 11,887...